quadrivalent HPV vaccine

BIOLOGICAL9 trials

Conditions

Autoimmune DiseaseBone Marrow Transplant InfectionCervical CancerCervical Cancer PreventionCervical NeoplasmsCervix CancerEvidence of Liver TransplantationGenital Warts

Phase 1

Immune Response and Durability of Human Papillomavirus Antibodies in Vaccinated Adolescents After Hematopoietic Stem Cell Transplantation: A Pilot Study

Active, not recruitingTCTR20240825001

Faculty of medicine Ramathibodi hospital, Mahidol universityImmunogenicity of two dose quadrivalent HPV vaccine in Adolescent after hematopoietic stem cell transplant. hematopoietic stem cell transplant, quadrivalent HPV vaccine, Immunogenicity

Start: 2024-07-25Target: 30Updated: 2026-08-03

Phase 2

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

CompletedNCT00604175

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Sexually Transmitted Diseases

Start: 2008-02-29End: 2012-11-30Updated: 2021-11-04

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

NCT04096911

Buhai WangCervical Cancer, Cervical Neoplasms, Cervix Cancer +1

Start: 2019-07-31End: 2021-03-31Target: 20Updated: 2019-09-20

Phase 3

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

CompletedNCT01461096

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2012-03-31End: 2016-01-31Updated: 2021-11-02

ICI-VPH: Impact of HPV Immunisation Schedules Against HPV

CompletedNCT02009800

CHU de Quebec-Universite LavalHuman Papillomavirus Infections

Start: 2013-11-30End: 2021-12-31Updated: 2022-04-28

Immunogenicity of HPV Vaccine in Immunosuppressed Children

CompletedNCT02263703

The University of New South WalesAutoimmune Disease, Bone Marrow Transplant Infection, Evidence of Liver Transplantation +3

Start: 2007-05-31End: 2016-12-31Updated: 2024-05-08

Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts

CompletedNCT02750202

University of PretoriaGenital Warts

Start: 2018-07-01End: 2025-07-31Updated: 2026-01-23

Phase 4

A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia

Not yet recruitingNCT07256912

International Agency for Research on CancerCervical Cancer Prevention, HPV Vaccination, Immunogenicity +3

Start: 2026-04-01End: 2029-01-15Target: 1266Updated: 2026-03-24

Unknown Phase

Immune Memory After Papillomavirus Vaccination

CompletedNCT01505049

Emory UniversityHealthy Volunteers

Start: 2012-01-31End: 2015-01-31Updated: 2015-07-21

JAMA Network Open2025-07-082 citations

Sintilimab plus HPV vaccine for recurrent or metastatic cervical cancer

Journal for ImmunoTherapy of Cancer2024-11-016 citations

Efficacy and safety of combining PD-1 blockage and human papillomavirus vaccine for patients with relapsed/refractory advanced cervical cancer.

Journal of Clinical Oncology2023-06-01

Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.

2019-08-0811 citations

A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298

Clinical Infectious Diseases2018-04-03133 citations

Immunogenicity and persistence of immunity of a quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children.

2016-07-0919 citations

Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women

Clinical Infectious Diseases2014-04-09158 citations